Navigation Links
Brainlab Announces FDA 510(k) Clearance for New HybridArc™ Software for Radiosurgery
Date:5/10/2011

MUNICH, May 10, 2011 /PRNewswire/ -- Brainlab has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its HybridArc™ radiosurgery planning solution. This innovative software package will enable healthcare professionals to increase the efficiency of existing Linac (linear accelerator) radiosurgery hardware and offer fast, high precision volumetric arc radiosurgery treatment without the need for costly hardware upgrades.

HybridArc expands upon the clinically proven and well-established Dynamic Arc stereotactic treatment technique to offer high dose conformity to the target, while sparing nearby organs and offering less residual dose when compared to other techniques such as rotational Intensity Modulated Radiotherapy.

With over 20 years of experience in stereotactic radiosurgery for small field treatments of the brain and spine, Brainlab has facilitated high accuracy treatments for hundreds of thousands of patients worldwide. Developed with highest accuracy in mind, HybridArc uses an adaptive dose calculation matrix that takes into account the different parameters affecting dose distribution to provide the necessary precision when opting for stereotactic radiosurgery. By using software automation, HybridArc calculates plans typically within a few minutes. Coupled with reduced treatment times, more patients can potentially benefit from advanced radiosurgery. From planning to patient treatment, HybridArc ensures clinicians can meet the demands of high dose single fraction radiosurgery.

Thierry Gevaert, medical physicist at Universitair Ziekenhuis, Brussels, Belgium, who will be using the new system at his radiosurgery center, comments: "We have looked at HybridArc as a cost-effective way to expand and improve on the capabilities offered by our current radiosurgery system. By using HybridArc we can get the most from our treatment machine, and treat more patients with precision and speed without having to invest in
'/>"/>

SOURCE Brainlab
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X-ray Based Navigation
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... (PRWEB) April 21, 2015 Staying true ... to craft a digital product that makes the world ... with Global Biological Standards Institute (GBSI) to redesign their ... clean, and most importantly, strategy-based. , "Biomedical research is ... - much less to promote it in a narrative ...
(Date:4/21/2015)... LA JOLLA, Calif. , April 21, 2015 ... (JCVI), a not-for-profit genomic research organization, published a ... manipulate a type of microalgae called diatoms. The ... , Ph.D. and senior author Philip Weyman ... methods will enable better understanding of diatom genetics ...
(Date:4/21/2015)... 21, 2015 AbilTo, Inc., the nation,s leading ... submission has been accepted as a presentation to be ... taking place on June 5-6, 2015 in Boston, ... American Diabetes Association, the cost of diabetes to the ... a result of increased inpatient, outpatient, and pharmacy costs, ...
(Date:4/21/2015)... 21, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ... Phase 1 study of MM-141, a bispecific antibody targeting ... oral session by Dr. Mansoor Saleh , MD ... Meeting in Philadelphia, PA.  The ... a monotherapy and in combination with everolimus or with ...
Breaking Biology Technology:Visceral Tells GBSI’s Story Within 30 Seconds of Attention 2Visceral Tells GBSI’s Story Within 30 Seconds of Attention 3Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 3AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 2AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5
... Jan. 31 Koronis Pharmaceuticals, Inc., a,biotechnology company ... the appointment of Daniel H. Petree and George ... Mr. Petree is a founder and member ... in life science companies. Prior to forming P2,Partners, ...
... EVENT ... DATE, Publication of the Annual Report for 2007 ... Wednesday, April 23, 2008, Publication ... 2008, Publication of the Interim Report for the Wednesday, August 27, 2008 ...
... UPTON, NY - In an achievement some see as ... Department of Energy,s Brookhaven National Laboratory have for the ... three-dimensional, ordered, crystalline structures of nanoparticles (particles with dimensions ... engineer such 3-D structures is essential to producing functional ...
Cached Biology Technology:Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors 2Genmab's Financial Calendar for 2008 2DNA technique yields 3-D crystalline organization of nanoparticles 2DNA technique yields 3-D crystalline organization of nanoparticles 3
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/20/2015)... The announcement comes as demand for fire ... Ireland,s foremost records management company, has ... an impressive track record of clients within the first 12 ... management sector in Dubai . As a ... employ a further eight staff members at its Irish headquarters. ...
(Date:4/17/2015)... Increasing adoption in ... to drive biometric systems market in ... According to a recently released TechSci Research ... biometric systems market in Saudi Arabia ... CAGR of over 22% through 2020. The market ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... WASHINGTON -- The most effective way to prevent the deliberate ... housed in laboratories across the U.S. considered to potentially pose ... culture of trust and responsibility in the laboratory, says a ... the laboratory environment will be critical for identifying and reducing ...
... that the pace of biodiversity loss is worsening in ... Cape Town October 13-16 for the DIVERSITAS Open Science ... of biodiversity have continued to accelerate. Since 1992, the ... than the size of California has been converted mostly ...
... to the AZTI-Tecnalia researchers, the first estimations of the geographical ... undertaken migrations between the Azores and Portugal during the winter, ... and also that it had dived, during the winter, to ... was tagged 26 of August 2008 in the Gulf of ...
Cached Biology News:Securing biological select agents and toxins will require developing a culture of trust 2Securing biological select agents and toxins will require developing a culture of trust 3Juvenile bluefin tunas can dive to depths of more than 1000 meters 2
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
Phospho-Cyclin D1 (Thr286) Antibody...
Biology Products: